Results with ACTH and spironolactone in severe cases of myasthenia gravis.
D000293:Adolescent; D000324:Adrenocorticotropic Hormone / Q000009:adverse effects / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D007362:Intensive Care Units; D008297:Male; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000188:drug therapy*; D013148:Spironolactone / Q000627:therapeutic use*
D013148:Spironolactone; D000324:Adrenocorticotropic Hormone